Original news and analysis on international IP policy
The South Centre, a Geneva-based intergovernmental organisation, is gearing up its work on intellectual property by launching a new programme on innovation, access to knowledge and intellectual property. The centre says it already sees the results of the programme in…
Por Martin Vaughan para Intellectual Property Watch WASHINGTON, DC – Activistas de la salud pública han condenado las condiciones acordadas recientemente por Colombia, Perú y países de Centroamérica en las negociaciones comerciales bilaterales con Estados Unidos. Estas condiciones obligan a…
Officials holding consultations at the World Trade Organization today on whether geographical indication (GI) protection for wines and spirits should be extended to other products completed a list of questions on the issue, but made no progress on bridging differences.…
Nations debating whether to harmonise national patent systems have turned their focus to developing country demands to include requirements that patent filers disclose the origin of genetic material and traditional knowledge. The debate is taking place in a 10-12 April…
India today floated a suggestion for joint meetings of two key committees at the World Intellectual Property Organization in a move that could change the way patents are addressed. The proposal could elevate biodiversity issues of concern to developing countries…
Discussions on an international regime on the sharing of benefits deriving from genetic resources at a recent United Nations conference in Brazil focused mainly on procedure, leading some sources to argue that developed countries tried to derail the process. The…
A much-anticipated World Health Organization (WHO) report by a special commission looking at the relationship between intellectual property rights and research and development into diseases disproportionately affecting developing countries, makes some 50 recommendations on how to improve the situation. The…
It is “misleading” and “counter-productive” to assert that a pharmaceutical company’s filing for a patent on a HIV/AIDS drug in India will limit access to the drug in the future, GlaxoSmithKline said in response to an objection submitted today in…
Two Indian HIV/AIDS networks and an international group of lawyers today submitted a protest to the first application for a patent for an HIV/AIDS drug filed in India. The opportunity to stage a “pre-grant opposition” is the “beauty of the…
BRUSSELS – A consumer-led conference on intellectual property touched on a wide range of issues during its second day, from whether the $9 physical production costs of CDs are saved through digital distribution, to what would be an ideal reform…